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Hodgkin-Reed Sternberg (H-RS) cells, which are the malignant
cells in Hodgkin’s disease (HD), clonally derive from germinal
centre B-cells. The occurrence of somatic mutations rendering
potential functional immunoglobulin (Ig) gene rearrangements
non-functional were described as a characteristic feature of H-RS
cells, leading to loss of expression of a high affinity antibody in
these cells (Küppers and Rajewsky, 1998). Although under physi-
ological conditions those cells would be committed to undergo
programmed cell death, H-RS cells do escape apoptosis. Thus, the
mechanism leading to apoptosis resistance of H-RS cells should be
further elucidated since it plays a crucial role in the development
of Hodgkin’s lymphoma. 
Recently, evidence for the implication of IkBa as a tumour
suppressor gene was obtained in some cases of HD. In 2 out of 8 HD-
derived cell lines deleterious mutations were detected in one allele
while the other allele was lost. Moreover, fatal clonal mutations
affecting the IkBa gene were also observed in H-RS cells obtained
from 2 out of 5 HD biopsy specimen, most probably leading to the
expression of a truncated IkBaprotein (Jungnickel et al, 2000). Since
IkBa downregulates NFkB, loss of function of IkBa would lead to
constitutive activation of NFkB mediating anti-apoptotic signals.
Indeed constitutive activation of NFkB in H-RS cells can be detected
in a substantial proportion of HD cases (Bargou et al, 1997). On the
other hand, as was already mentioned, cases of HD in which the H-
RS cells express wild type IkBa exist. For example in L1236 cell
line, which is known to be clonally derived from H-RS cells, presence
and transcription of two IkBa wild type alleles was demonstrated
making an alteration of IkBa leading to the transformation of these
lymphoma cells very unlikely. Thus, the identification of clonal
genetic alterations for which H-RS cells were selected for in these
cases, is needed. 
Since IkBa was already identified to be involved in HD patho-
genesis as a tumour suppressor gene, further studies should address
the identification of loss of function of other genes in HD. Recently,
Hasse et al (1999) provided evidence for the presence of loss of
heterozygosity (LOH) in H-RS cells. Four different loci were
investigated by amplification for microsatellite DNA. In 6 out of 7
cases LOH was detected affecting at least one of these loci.
Regions of LOH occurring in H-RS cells may refer to the presence
of tumour suppressor genes that are involved in the pathogenesis of
Hodgkin’s lymphoma. It would thus be of interest to further charac-
terize the pattern of LOH by analysing additional microsatellite loci
covering nearly each arm of every chromosome. However, since
HD derived lymphoma tissues consist only of a small amount of H-
RS cells (up to 5%) comprehensive allelotyping of tumour cells
cannot be performed easily because of the need of a ‘pure’
lymphoma cell population. Efforts to enrich primary H-RS cells
from lymph node suspensions were successful but only a small
number of cells were recovered and still a substantial proportion of
other cells were admixed (Irsch et al, 1997). Established HD
derived cell lines which are supposed to be of H-RS cell origin and
thus most probably represent the lymphoma cell population could
not be used for allelotype analysis since the germ line allelotype of
the patient could not be determined due to the lack of normal
control tissues of the respective patient. 
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Summary Hodgkin-Reed Sternberg cells are derived from germinal centre B-cells in most cases. Somatic mutations affecting their
rearranged immunoglobulin genes were detected, rendering potential functional rearrangements non-functional. Under physiological
conditions such cells would be designated to undergo apoptosis within the germinal centre. In search for the specific transforming event that
prevents Hodgkin-Reed Sternberg cells from programmed cell death, cytogenetic analyses were broadly performed but did not reveal specific
chromosomal aberrations. Analysis of these cells on the molecular level is difficult to perform due to the scarcity of the cells in the lymphoma
tissue and the given limitations of in situ studies. To overcome these limitations, the cell line L1236, known to be derived from Hodgkin-Reed
Sternberg cells in situ, was chosen for allelotype analysis. Using a panel of microsatellite loci assigned to nearly all chromosomal arms,
regions of loss of heterozygosity were detected on chromosomal arms 6p, 9q and 17p. The size of lost segments was estimated by
amplification of additional microsatellite loci mapped to the respective regions. Further analyses of single Hodgkin-Reed Sternberg cells will
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doi: 10.1054/ bjoc.2000.1593, available online at http://www.idealibrary.com on  http://www.bjcancer.comThe recently established EBV-negative cell line L1236 was
shown to be derived from the patient’s clonal H-RS cell population
by amplifying identical Ig gene rearrangements from the cell line as
well as from H-RS cells micromanipulated from fresh frozen
sections of the patient’s bone marrow (Kanzler et al, 1996). Thus,
L1236 represents a valid population of H-RS cells. From the same
patient a bone marrow sample was obtained during complete
clinical remission that could be analysed to define the germ line
allelotype of the patient. In the present study allelotype analyses
using a comprehensive panel of oligonucleotides in order to
amplify microsatellite DNAs located on each arm of each chromo-
some were performed to detect regions of clonal loss of hetero-
zygosity in L1236 cells that may have implications for the
pathogenesis of HD. 
MATERIALS AND METHODS 
Cell line L1236 
L1236 is an EBV-negative cell line which was established from
the peripheral blood of a patient suffering from relapse of HD of
mixed cellularity subtype (Wolf et al, 1996). Its origin from
primary H-RS cells was proven by amplification of identical Ig
gene rearrangements from the cell line as well as from H-RS cells
micromanipulated from the patients bone marrow during relapse
(Kanzler et al, 1996). The cell line IARC 277 is an EBV immortal-
ized lymphoblastoid cell line and was kindly provided by G Lenoir
(Lenoir et al, 1985). This cell line was used as a control population
to determine the sensitivity of detection of L1236 cells within a
population of non-malignant B-cells. 
Bone marrow cells 
The bone marrow cells (BMC) of the same patient whose periph-
eral blood cells were used to establish the cell line L1236, were
harvested for autologous bone marrow transplantation during
complete clinical remission (for case report of the patient see Jox
et al (1998) and used as normal tissue control for determination of
the patient’s germ line allelotype. 
Oligonucleotides 
According to Osborn and Leech (1994) oligonucleotides were
chosen for amplification of microsatellite DNA representing each
arm of every chromosome except for the short arms of the acro-
centric chromosomes 13, 14, 15, 21 and 22 (see Table 1). To map
the extent of detected loci with LOH neighbouring micro-
satellite loci obtained from the Genethon linkage map
(http://www.genethon.fr/genethon_en.html) and the NCBI data
base (http://www.ncbi.nlm.nih.gov/) were further analysed (for
sequence information of oligonucleotides and references of
microsatellite loci see Table 2). For amplification of the H-RS cell
specific VH1 Ig gene rearrangement oligonucleotides were chosen
from the leader region (VH1L: 5¢-¢TCACCATGGACTGGAC-
CTGGAG-3¢), from the FR1 region (F10VH1: 5¢-GCCTGGGGC-
CTCAGTGAAGGT-3¢) as well as from the CDR3 region (3H1:
5¢-GTGGCCATTGTAGTTCCCAC-3¢). 
DNA extraction 
For amplification of microsatellite loci high molecular weight
DNA was extracted from L1236 cells and the patient’s bone
marrow using standard protocols (Sambrock et al, 1989). PCR
sensitivity for amplification of the H-RS cell specific VH1 Ig gene
rearrangement from DNA obtained from the patient’s bone
marrow was estimated by mixing L1236 cells to IARC 277 cells in
various concentrations. 
PCR analysis 
PCR analyses were performed in a reaction volume of 50m
containing 50 mM KCl, 2.5 mM MgCl2, 200 mM dNTP, 25 mM of
each primer. 1 unit of Taq DNA polymerase (Promega, Mannheim,
Germany) was added during the first denaturation step. For detec-
tion of LOH 5 ng template DNA was used. For all reactions PCR
consisted of 60 s at 95˚C, 120 s at different annealing temperatures
given in Table 1 and Table 2 and 120 s at 72˚C for 35 cycles,
followed by a final extension for 7 min at 72˚C. For detection of
the VH1 gene rearrangement PCR consisted of two rounds of PCR
at 90 s at 95˚C, 30 s at 57˚C and 80 s at 72˚C for 40 cycles,
followed by a final extension for 7 min at 72˚C. PCR products
were separated on an agarose gel and visualized by ethidium
bromide staining or on a denaturing polyacrylamide gel followed
by silver staining, respectively. 
Southern blot analysis 
PCR products were separated by agarose gel electrophoresis and
transferred onto a nylon filter (Gene Screen Plus; NEN, Boston,
USA) using standard methods (Sambrock et al, 1989). To detect
the H-RS cell specific VH1 gene rearrangement an internal
oligonucleotide (5-1 CDR2: 5¢-CCGGTGTTGGCTCGACAATG-
3¢) was labelled and hybridized using the ECL kit (Roche
Biochemicals, Mannheim, Germany) according to the manufac-
turer’s protocol. 
Silver staining of DNA separated on polyacrylamide
gels 
PCR products were separated in a 5% polyacrylamide gel
(Electrophoresis apparatus Model S2, Renner, Eggenstein,
Germany). For fixation of DNA the gel was incubated in 10%
glacial acetic acid (Baker Chemikalien, Gross Gerau, Germany)
for 10 min and then rinsed three times in distilled water. Thereafter
the gel was impregnated in an AgNO3 solution (Merck,
Darmstadt, Germany) (1 g l–1) containing 0.05% formaldehyde
(Baker Chemikalien, Gross Gerau, Germany) for 30 min. After
decanting the AgNO3 solution the gel was rinsed for a few se-
conds in distilled water. For reduction of AgNO3 the gel was
incubated in a solution consisting of NaCO3 (30 g l –1) (Merck,
Darmstadt, Germany), sodium thiosulphate (2 mg l–1) (Merck,
Darmstadt, Germany) and formaldehyde (0.05%). The reduction
process was stopped with 10% glacial acetic acid. 
RESULTS 
Analysis of the patient’s bone marrow cells for minimal
residual disease 
For allelotype analysis of lymphoma cells a nearly pure popula-
tion of non-malignant cells obtained from the same patient is
needed to determine the patient’s germ line allelotype. Therefore,
the patient’s bone marrow cells (BMC), which were obtained
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minimal residual disease. The VH1 gene rearrangement of L1236
cells was already used to detect the patient’s H-RS cells in various
tissues obtained during the course of the disease (Jox et al, 1998).
To test the patient’s BMC for the presence of H-RS cells a semi-
nested PCR was performed. Simultaneously, L1236 cells were
mixed with B-lymphoblastoid cells (IARC 277) in various
concentrations to estimate the sensitivity of the PCR approach.
Approximately 5 ng DNA obtained from the patient’s bone
marrow cells as well as from the mixture of cell lines were used as
template in the first PCR round. In the second round 1 ml of the
first round was utilized. Given the sensitivity of the detection of
one L1236 cell within 104 1ARC 277 cells in subsequent Southern
blot analysis of the PCR products, no H-RS cells were detected in
the BMC sample. Thus, BMC cells do not contain H-RS cells in a
proportion that could interfer analysis of the patient’s allelotype.
For allelotype analysis 5 ng of BMC DNA was subsequently use
as control. 
Allelotyping of L1236 cells revealed LOH on three
chromosomal loci 
Using a comprehensive set of 112 oligonucleotides (Osborn and
Leech, 1994) to amplify at least one microsatellite locus on each
chromosomal arm except for the short arms of acrocentric chromo-
somes, the amplification of most of the microsatellite loci revealed
no LOH. Of the total number of 56 amplified microsatellites, 43 were
informative revealing the detection of heterozygosity in the patient’s
germ line allelotype. On three chromosomal loci i.e. 6p (FTHP1),
9q(D9s15), and 17p (L02016) LOH was detected (Table 1).
Mapping the extent of LOH on the affected
chromosomal loci 
To map the extent of LOH on each chromosomal area that was
detected to be involved by allelic loss, additional microsatellite
loci, which are located in the proximity of the initial locus, were
identified for amplification (Table 2). On chromosome 6p, 12
repeats were further amplified. Two regions of LOH were defined,
mapping to the chromosomal region 6p21-22 (see Table 2 and
Figure 1). Each region comprises about 4–6 megabases whereby in
the proximal region retention of an area of heterozygosity occurs
(Figure 1A and Table 2A). Similarly the extent of LOH on 9q was
mapped by amplifying 15 additional microsatellite loci. The prox-
imal breakpoint was found to be located between D9s1777 and
D9s1876 while the distal breakpoint is located between D9s1812
and D9s278. Thus, the region of LOH comprises about 36
megabases (Figure 1B and Table 2B). For further analysis of LOH
on 17p, 8 additional loci were amplified. 5 loci chosen from 17p
revealed allelic loss allowing to map the breakpoint between
D17s926 and D17s805. Within this region amplification of one
microsatellite locus revealed retention of heterozygosity. Thus,
allelic loss on chromosome 17 extends to nearly the whole short
arm and comprises about 27 megabases whereby a region of
heterozygosity was retained (Figure 1C and Table 2C). 
DISCUSSION 
The detection of specific chromosomal aberrations in HD may be
hampered by the small amount of H-RS cells in the primary tissue
and their low mitotic index compared to the surrounding non-
malignant lymphocytes. Conventional cytogenetic analysis of the
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British Journal of Cancer (2001) 84(3), 381–387 © 2001 Cancer Research Campaign
Table 1 Allelotyping of L1236 cells 
Chromosome (band) Locus Result (L1236) Chromosome (band) Locus Result (L1236) 
1p21 AMY2B heterozygous 9q34.1 ASS not informative 
1q21-23 APOA2 not informative 10p11,2-pter D10S89 heterozygous 
1q32-q44 DIS103 heterozygous 10p11.2-pter D10S111 heterozygous 
2p23-pter TPO heterozygous 10p D10S179 not informative 
2p12 CD8A not informative 11p13-15.1 D11S419 heterozygous 
2q33-35 D2S72 not informative 11q13 D11S534 heterozygous 
3q21-qter ACPP not informative 11q23.2-24 D11S836 not informative 
4p11-15 D4S174 heterozygous 12p12-pter F8VWF heterozygous 
4p12-13 GABARBI heterozygous 12q22-q24.33 D12S60 heterozygous 
4q25-34 D4175 heterozygous 13q12 FLT-1 heterozygous 
4q35-qter D4S171 not informative 13q11-12.1 D13S115 heterozygous 
5p15 D5S268 heterozygous 14q31 D14S34 heterozygous 
5p15.1-15.3 D5S117 heterozygous 15q26.1 FES not informative 
5q21-22 D5S346 heterozygous 16p13 D16S292 heterozygous 
6p24-25 F13A1 heterozygous 16q21 D16S265 heterozygous 
6p21.3-p24 D6S109 not informative 17p13.1 TP53 LOH 
6p12-21.3 FTHP1 LOH 17q11.2-12 D17S250 heterozygous 
6q23.1 D6S87 heterozygous 17q12-21 D17S588 heterozygous 
7p11.2-12 EGFR heterozygous 18p11.21-pter D18S40 heterozygous 
7q31 D7S23 heterozygous 18q21.2-21.3 D18S35 not informative 
7q31 CFTR heterozygous 19q12 D19S49 heterozygous 
8p22 LPL heterozygous 20p12 D20S27 heterozygous 
8p11.2-11.1 D8S135 heterozygous 20q12 D20S46 heterozygous 
8p11.1-21.1 ANKI heterozygous 21p11.2 D21S120 not informative 
8q22-qter D8S161 heterozygous 21q22.3-qter D21S171 heterozygous 
9p22-pter D9S54 heterozygous 22q D22S156 heterozygous 
9q13-21 D9S15 LOH 22q11.2-13.1 TOPIP2 heterozygous 
9q33 GSN heterozygous Xq21.1-23 DX454 not informative 
Amplification of 56 microsatellite loci revealed the detection of LOH at three chromosomal loci i.e. 6p12-21.3, 9q13-21 and 17p13.1. The microsatellite loci and
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Table 2 A–C Mapping the extent of LOH on three chromosomal loci 
Chromosome (band) Comp Locus Accession Oligonucleotides (5’-3’) A-Temp. Result (L1236) 
A
6p22 28.252 D6s276 Z16711 atcatccccagaaggaacact
gtgcaacttgttcctcctttg 57 ˚C LOH 
6p22.3-p21.3 32.300 D6s306 Z17120 agaattgaccttccaattcacc
caaatttgaagtggtggggt 53 ˚C heterozygous 
6p21.3 36.035 D6s439 Z23903 aactcaggcttcacaactttgg
agcctcagggaagacacatttt 59 ˚C LOH 
6p21.3 36.855 D6s1629 Z53381 gaacgtactgtcccacacactt
tgatgctagggaaggggcatct 61 ˚C LOH 
6p21.3 38.016 D6s1576 Z52627 aaaactattgggggagatgga
ggcctgtgtaagtgcattcta 56 ˚C heterozygous 
6p21.3 38.987 D6s1610 Z53131 ccacttctcctggtgagataga
gttaggaatttccagcagagcc 61 ˚C heterozygous 
6p21.2-p21.1 40.531 D6s1562 Z51063 agtgcaggtccttcttcatacc
tggaactaagctttacagcccc 61 ˚C LOH 
6p21.2-p21. 42.192 D6s426 Z23755 tctgttgagttctccctctccc
tggaaccagaaactgtggcata 57 ˚C LOH 
6p21.2-p21.1 44.305 D6s1632 Z53424 caccagtactatgccaggcata
tgagggctctggttcttattgc 61 ˚C LOH 
6p21.2-p21.1 44.396 D6S1566 Z52556 aaatatacctcttcactggcc
cagcattatgttctcctgtct 57 ˚C LOH 
6p12 44.442 D6S452 Z24209 ggatctaaatctcacccgtac
aagttctgggtgattcaggt 55 ˚C LOH 
6p21.2-p21.1 44.688 D6s438 Z23901 taagtgaggggaacatcacaga
acatgtgcagaatgagcagatt 62 ˚C heterozygous 
B
9p12-q11 55.403 D9s1777 Z52124 gtaccaaggcaatgctggttca
agctcccaaatacctgttaccc 61 ˚C heterozygous 
9q13-q21.1 58.237 D9s1806 Z52772 gaggcagaggttgcagttagaa
tggcaagtagaagggagcaaca 61 ˚C not informative 
9q13-q21.1 59.182 D9s1876 Z51715 gatgtacccagagaagtctcg
gatctatttctactcactgccag 57 ˚C LOH 
9q13-q21.1 60.032 D9s1837 Z53339 accaaactgttcatgatggtgg
tttttcttttccctctgcccca 56 ˚C LOH 
9q13-q21.1 61.086 D9s1822 Z53100 gtttggcttctgctgtaagggt
ctgagtgtttcaggaagcacca 61 ˚C LOH 
9q12-q21.1 70.836 D9s284 Z24432 acttacccacatcatctgtgag
accacataaaaactctctgcc 55 ˚C not informative 
9q21.1 73.167 D9s175 Z17021 gatagcagtaagttcttcctgg
cctcacaaactcttatcagcc 59 ˚C LOH 
9q21.3-q22 85.550 D9s1807 Z52789 tctcccaaagttgaagagcatt
ttagtctgtggcacaagtcag 55 ˚C LOH 
9q21.1-q22 85.765 D9s1834 Z53271 aagagagagagacagacacac
ggttaagtaactggtggagga 57 ˚C LOH 
9q21.3-q22 86.971 D9s1860 Z53953 tgtccccaagactttcttaagg
gatcatgaagtgggcataatgc 56 ˚C not informative 
9q13-q21.1 91.419 D9s153 Z16442 cagcccaaatggactaagaca
cagttctgaggccatatgtct 57 ˚C not informative 
9q21-q22.1 92.864 D9s1785 Z52241 gtactgggcaatatgcaaagg
taatggaggtgcagagtacac 57 ˚C LOH 
9q21-q22.1 93.281 D9s1877 Z51753 taagataggggctttgggctca
tgccactgggtcttaacgtgta 61 ˚C not informative 
9q22.1 95.348 D9s1812 Z52886 ccatgactgcttcacccaacaa
tgtcccctaactgctttggatg 61 ˚C LOH 
9q22.1-q22.2 96.840 D9s278 Z24157 gaatgttcccaggcactgata
agggttttttggagacacaga 56 ˚C heterozygous newly established  H-RS cell line L1236 revealed a grossly aber-
rant karyotype (Wolf et al, 1996; Fonatsch et al, 1999). The
number of chromosomes varies from metaphase to metaphase. A
similar observation was made for H-RS cells obtained from freshly
prepared single cell suspensions of biopsy materials using inter-
phase FISH in combination with immunophenotype analysis
(Weber-Matthiesen et al, 1995) indicating an intrinsic chromo-
somal instability of these cells as already suggested by others
(Fonatsch et al, 1982; Palzetti et al, 1999). Thus, conventional
cytogenetic analyses as well as interphase FISH may be of limited
value to define clonal aberrations present in each H-RS cell. 
The molecular allelotype analysis of tumour cells enables the
detection of clonal loss of heterozygosity by the amplification of
microsatellite DNA using PCR and may thus offer an advantage
compared to cytogenetic analysis. So far, allelotyping of H-RS
cells representing every arm of nearly all chromosomes was not
performed because of the need of a pure lymphoma cell population
and the difficulties to enrich H-RS cells from lymph node suspen-
sions et al, 1997). In addition, the allelotype of HD-derived cell
lines could not be determined since autologous non-affected tissue
samples were not available for comparison. For the H-RS cell line
L1236, bone marrow cells of the respective patient obtained
during clinical complete remission were available, that were
screened for the absence of H-RS cells using clone specific
oligonucleotides to amplify the H-RS cell specific IgH gene
rearrangement. Thus, the H-RS cell line L1236 together with the
patient’s normal bone marrow cells for the first time enabled
comprehensive allelotype analyses of H-RS cells. 
Allelotype analyses revealed detection of LOH on 6p, 9q and
17p. The extent of LOH on each chromosome was estimated by
amplification of adjacent microsatellite loci and was found to
range between 4 and 36 megabases. Especially on chromosome 17
nearly the whole short arm of one chromosome was lost. Since
the corresponding chromosomal regions were not involved in
LOH in the H-RS cell line L1236 385
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C
17p13 2.789 D17s926 Z23575 ggctgaagtgggaagattgctt
tgaagttccgcagaaggctgtt 61 ˚C LOH 
17p13.3 6.033 D17s1828 Z53084 ccacaggtgcactcacagattt
cctggattcagccatacctgaa 61 ˚C heterozygous 
17p13.3 6.298 D17s1876 Z51792 gctgcttctgcaaagatgac
gttgagattacagacgtgagc 61 ˚C LOH 
17p13.1 11.215 D17s1791 Z52229 cctgaagatgtttctggagcag
acatttgtgggtgggtggagtt 61 ˚C LOH 
17p11.2 16.066 D17s1856 Z53861 gcatggtggtaggcacctatat
tagcagcagtccccaacctttt 61 ˚C LOH 
17p11.2-p11.1 27.910 D17s805 Z17037 ggctgagattgcaccattgc
acagaggaccatgtgtacac 61 ˚C LOH 
17p11.1 27.947 D17s1871 Z51496 gcacgtggcctattatgagact
ggtagggttctccagagaaaca 61 ˚C heterozygous 
17q12 37.973 D17s927 Z23601 cctcctccaaggaaagaactga
tgacattggaagtctgacctgg 61 ˚C heterozygous 
By amplification of additional microsatellite loci, the extent of LOH was estimated on the three loci for which LOH was detected by allelotype analysis. The
location of the microsatellite on the chromosome is given as referred to the Genatlas database by Jean Frezal (http://bisance.citi2.fr/GENATLAS/link_an.html)
and to The Genetic Location Data Base, Department of Human Genetics, University of Southampton, Genetic Epidemiology Research Group
(http://cedar.genetics.soton.ac.uk/public_html/Idb.html). Comp: composite location ordered by the distance of the locus from the p-telomere of the chromosome
in megabases, A-temp: annealing temperature. 



















Figure 1 A–C Loss of heterozygosity in L1236 cells. 
Allelotype analysis of L1236 cells was performed by amplification of
microsatellite loci. Three regions of LOH were detected on 6p, 9q 
and 17p and analysed in detail. The ideograms of the respective
chromosomes are given and the analysed regions are indicated by black
vertical lanes. Examples of PCR results are given on the right of each
ideogram ordered by the distance of the locus from the p-telomere of the
chromosome. Examples of LOH are marked by arrows. Further information
on the location of each microsatellite locus is given in Table 2. BMC: bone
marrow cellschro mosomal translocations and did not show microscopically
visible deletions (Wolf et al, 1996; Fonatsch et al, 1999). LOH
most probably resulted from mitotic recombination events. The
retention of heterozygosity within regions of LOH further supports
this view indicating that several recombination events have led to
allelic loss. The detection of LOH using PCR indicates that these
alterations represent clonal events that are present in most if not all
L1236 cells. However, since L1236 cells grow in culture, it can not
be thoroughly excluded that LOH in L1236 is caused by genetic
instability in vitro and reflects the presence of various subpopula-
tions expanding during culturing. 
LOH affecting a chromosomal region in a tumour cell often
points to the presence of a tumour suppressor gene that is involved
in the pathogenesis of the tumour. The chromosomal regions
affected by LOH in L1236 cells are too large to allow for the iden-
tification of a candidate tumour suppressor gene involved in HD.
However, occurrence of LOH comprising these regions were
described for other tumour entities, supporting the view that loss
of a particular gene within these areas can contribute to malignant
transformation. The well characterized tumour suppressor gene
p53 maps to 17p. Analysis of exons 5 to 10 of the remaining p53
allele in L1236 cells revealed wild-type sequence (data not shown)
further supporting the view that p53 is usually not altered by
somatic mutation in H-RS cells (Montesinos-Rongen et al, 1999).
Frequent LOH on 17p independent of p53 has also been observed
for a variety of solid tumours (Chattopadhyay et al, 1997; Grebe
et al, 1997; Steichen-Gersdorf et al, 1997; Konishi et al, 1998;
Liscia et al, 1999) further providing evidence that other tumour
suppressor genes may map to 17p. The region on 6p that is
affected by LOH in L1236 cells covers the HLA locus. HLA-
haplotype loss may confer a selective advantage for tumour cells
and can be observed in a variety of neoplasias (Jimnez et al, 1999).
In addition, allelic loss of the tumour necrosis factor alpha gene
mapped to 6p21.3 was observed for colorectal cancer cells
(Honchel et al, 1996) probably contributing to the maintenance of
the malignant phenotype. Moreover, frequent allelic loss of a chromo-
somal fragment mapping to 6p21 was detected in diffuse large B-
cell non Hodgkin’s lymphoma (Nagai et al, 1999) further
suggesting the existence of a putative tumour suppressor gene
within this region. The presence of a tumour suppressor gene is
also suggested for the chromosomal region 9q13-q21.2 since
allelic loss of this region was frequently observed in carcinoma of
the bladder (Keen and Knowles, 1994). 
The relevance of allelic loss affecting the respective regions for
the development of HD cannot be estimated by analysis of a single
case. However, screening of L1236 cells for LOH enabled us to
identify single regions of interest which can now further be
analysed using single cell PCR on primary H-RS cells obtained
from lymph node suspensions of a large number of HD cases.
These analyses will reveal if LOH affecting 6p, 9q, or 17p is a
frequent event in HD. 
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